Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.
Other companies in C4 Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
C4 Therapeutics has a consensus price target of $10.83.
The stock price for C4 Therapeutics (NASDAQ: CCCC) is $3.455 last updated September 18, 2026 at 11:40 AM EDT.
There are no upcoming dividends for C4 Therapeutics.
C4 Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for C4 Therapeutics.
C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.